Literature DB >> 15374992

Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells.

Maen Abdelrahim1, Roger Smith, Robert Burghardt, Stephen Safe.   

Abstract

Sp proteins play an important role in angiogenesis and growth of cancer cells, and specificity protein 1 (Sp1) has been linked to vascular endothelial growth factor (VEGF) expression in pancreatic cancer cells. RNA interference was used to investigate the role of Sp family proteins on regulation of VEGF expression and proliferation of Panc-1 pancreatic cancer cells. Using a series of constructs containing VEGF promoter inserts, it was initially shown that Sp1 and Sp3 were required for transactivation, and this was primarily dependent on proximal GC-rich motifs. We also showed that Sp4 was expressed in Panc-1 cells, and RNA interference assays suggested that Sp4 cooperatively interacted with Sp1 and Sp3 to activate VEGF promoter constructs in these cells. However, the relative contributions of Sp proteins to VEGF expression were variable among different pancreatic cancer cell lines. Small inhibitory RNAs for Sp3, but not Sp1 or Sp4, inhibited phosphorylation of retinoblastoma protein, blocked G0/G1-->S-phase progression, and up-regulated p27 protein/promoter activity of Panc-1 cells; similar results were observed in other pancreatic cancer cells, suggesting that Sp3-dependent growth of pancreatic cancer cells is caused by inhibition of p27 expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15374992     DOI: 10.1158/0008-5472.CAN-04-0713

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  75 in total

1.  Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation.

Authors:  Indira Jutooru; Gayathri Chadalapaka; Ping Lei; Stephen Safe
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

2.  Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10.

Authors:  Susanne U Mertens-Talcott; Giuliana D Noratto; Xiangrong Li; Gabriela Angel-Morales; Michele C Bertoldi; Stephen Safe
Journal:  Mol Carcinog       Date:  2012-03-07       Impact factor: 4.784

3.  Sp1 phosphorylation by cyclin-dependent kinase 1/cyclin B1 represses its DNA-binding activity during mitosis in cancer cells.

Authors:  J-Y Chuang; S-A Wang; W-B Yang; H-C Yang; C-Y Hung; T-P Su; W-C Chang; J-J Hung
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

4.  Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth.

Authors:  Indira Jutooru; Gayathri Chadalapaka; Sandeep Sreevalsan; Ping Lei; Rola Barhoumi; Robert Burghardt; Stephen Safe
Journal:  Exp Cell Res       Date:  2010-05-08       Impact factor: 3.905

5.  Specificity protein 1 regulates fascin expression in esophageal squamous cell carcinoma as the result of the epidermal growth factor/extracellular signal-regulated kinase signaling pathway activation.

Authors:  Xiao-Feng Lu; En-Min Li; Ze-Peng Du; Jian-Jun Xie; Zhang-Yan Guo; Shu-Ying Gao; Lian-Di Liao; Zhong-Ying Shen; Dong Xie; Li-Yan Xu
Journal:  Cell Mol Life Sci       Date:  2010-05-26       Impact factor: 9.261

6.  MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma.

Authors:  Yuanyuan Wang; Min Li; Wenqiao Zang; Yunyun Ma; Na Wang; Ping Li; Tao Wang; Guoqiang Zhao
Journal:  Cell Oncol (Dordr)       Date:  2013-09-03       Impact factor: 6.730

Review 7.  [Pathogenesis of the ductal pancreatic adenocarcinoma: implications for future therapies?].

Authors:  G Schneider; R M Schmid
Journal:  Internist (Berl)       Date:  2005-02       Impact factor: 0.743

8.  Effect of tolfenamic acid on canine cancer cell proliferation, specificity protein (sp) transcription factors, and sp-regulated proteins in canine osteosarcoma, mammary carcinoma, and melanoma cells.

Authors:  H Wilson; G Chadalapaka; I Jutooru; S Sheppard; C Pfent; S Safe
Journal:  J Vet Intern Med       Date:  2012-04-27       Impact factor: 3.333

9.  Curcumin decreases specificity protein expression in bladder cancer cells.

Authors:  Gayathri Chadalapaka; Indira Jutooru; Sudhakar Chintharlapalli; Sabitha Papineni; Roger Smith; Xiangrong Li; Stephen Safe
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

10.  Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity.

Authors:  Zhiliang Jia; Yong Gao; Liwei Wang; Qiang Li; Jun Zhang; Xiangdong Le; Daoyan Wei; James C Yao; David Z Chang; Suyun Huang; Keping Xie
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.